UNICYCIVE THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-2.7M | — |
| FY2021 | — | $16.5M | $16.6M |
| FY2022 | — | $-466.0K | $455.0K |
| FY2023 | — | $-3.8M | $9.7M |
| FY2024 | — | $7.4M | $26.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-2.7M | — |
| FY2021 | — | $16.5M | $16.6M |
| FY2022 | — | $-466.0K | $455.0K |
| FY2023 | — | $-3.8M | $9.7M |
| FY2024 | — | $7.4M | $26.1M |